Fair Value Measurements - Additional Information (Details) - USD ($) |
Jun. 30, 2025 |
May 01, 2025 |
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Fair value, assets, transfers between levels | $ 0 | |
| DCx Biotherapeutics Corporation | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity ownership percentage | 9.99% | |
| Dilution protection rights received on sale of technology and other assets | $ 600,000 | $ 600,000 |